J&J challenges validity of asbestos tests after baby powder recall

By Becky Bargh | Published: 24-Oct-2019
Regulatory

The personal care giant says it will work with the FDA to ensure the integrity of the sample and the legitimacy of the tests

You need to be a subscriber to read this article.
Click here to find out more.

Johnson & Johnson (J&J) is challenging the validity of the tests that led to a recall of 33,000 baby talc products over asbestos contamination.

Tests were carried out by the FDA to identify the presence of the deadly substance in its products.

But J&J told Cosmetics Business that it is working with the FDA to

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • Johnson and Johnson
See more

You may also like

Regulatory

New J&J talc lawsuit first to seek medical monitoring for cancer

Read more
The proposed class action is the first to seek medical monitoring, or regular testing for female talc users to catch cancer early

Trending Articles

  1. L’Oréal faces six lawsuits over benzene contamination in acne treatments The US Judicial Panel on Multidistrict Litigation will begin hearings on the lawsuits at the end of the month
  2. Charlotte Tilbury setting spray withdrawal hits Puig shares The Barcelona-based conglomerate is the latest company to voluntarily withdraw product batches for quality issues
  3. FDA proposes standardised asbestos detecting in cosmetics containing talc A proposed rule would require makers of talc-containing cosmetic products to test for asbestos via an analytical approach
  4. Five make-up ingredients that may be harming you When you are purchasing make-up or skin care it is so important that you keep an eye out for ingredients that could be causing more harm than good. Here are five that you need to be wary of
  5. Drunk Elephant initiates voluntary product recall in the US The skin care brand said there was an isolated ingredient mix-up between preservatives and surfactants during production

Upcoming event

Launch Lab: Future-Forward Cosmetics – Beyond Packaging 2025 - WEBINAR

17 January 2025 See all

You may also like

Regulatory

New J&J talc lawsuit first to seek medical monitoring for cancer

The proposed class action is the first to seek medical monitoring, or regular testing for female talc users to catch cancer early
Regulatory

Johnson & Johnson to appeal $19 million owed to California cancer patient

The talc cancer trial involving 24-year-old Emory Hernandez Valadez was the first faced by J&J since its bankruptcy filing
Regulatory

Johnson & Johnson faces first new talc cancer trial since bankruptcy filing

Judge overseeing LTL Management’s Chapter 11 has allowed the trial to go ahead, as 24-year-old cancer patient Anthony Hernandez Valadez does not have long to live
Regulatory

US judge pauses J&J talc trials, but healthcare giant may face new suits

The 60-day freeze advances J&J’s second attempt to settle cases through subsidiary LTL Management’s bankruptcy proceedings
Regulatory

J&J's first quarter earnings plummet following $6.9 billion talc litigation charge

J&J originally proposed a $8.9bn settlement to resolve its ongoing talc litigation woes, and its subsidiary LTL Management has refiled for Chapter 11 bankruptcy
Regulatory

Johnson & Johnson proposes $8.9 billion for talc settlements

J&J subsidiary LTL Management has refiled for bankruptcy following Third Circuit rejection
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Beauty offers support to Turkey-Syria earthquake crisis

A 7.8-magnitude earthquake hit the countries on 6 February 2023, which has gone on to the claim the lives of 35,000 people
Subscribe now